High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

NCT00002784 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

344

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: filgrastim
DRUG: CMF regimen
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: epirubicin hydrochloride
DRUG: fluorouracil
DRUG: mesna
DRUG: methotrexate
DRUG: tamoxifen citrate
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: low-LET electron therapy
RADIATION: low-LET photon therapy

Sponsor

ETOP IBCSG Partners Foundation